Aldosterone: role in the cardiometabolic syndrome and resistant hypertension - Wikidata - awgldk - TriplyDB

Aldosterone: role in the cardiometabolic syndrome and resistant hypertension

Aldosterone: role in the cardiometabolic syndrome and resistant hypertension

http://www.wikidata.org/entity/Q33736838

about

Genetics of resistant hypertension: a novel pharmacogenomics phenotype Vascular disturbances in primary aldosteronism: clinical evidence Brain mineralocorticoid receptors in cognition and cardiovascular homeostasis Heart of the matter: coronary dysfunction in metabolic syndrome.Pleiotropic effects of the dipeptidylpeptidase-4 inhibitors on the cardiovascular system The involvement of aldosterone on vascular insulin resistance: implications in obesity and type 2 diabetes.The contributions of muscarinic receptors and changes in plasma aldosterone levels to the anti-hypertensive effect of Tulbaghia violacea Circulating aldosterone and natriuretic peptides in the general community: relationship to cardiorenal and metabolic disease.Cardiac hypertrophy and fibrosis in the metabolic syndrome: a role for aldosterone and the mineralocorticoid receptor Role of the Renin-Angiotensin system and aldosterone on cardiometabolic syndrome.Aldosterone and glomerular filtration--observations in the general population Central regulation of blood pressure by the mineralocorticoid receptor Myeloid mineralocorticoid receptor deficiency inhibits aortic constriction-induced cardiac hypertrophy in mice The multifaceted mineralocorticoid receptor Atorvastatin inhibits the apoptosis of human umbilical vein endothelial cells induced by angiotensin II via the lysosomal-mitochondrial axis.Update in endocrinology - primary hyperaldosteronism - from secondary hypertension towards metabolic syndrome and beyond.Abnormal aldosterone physiology and cardiometabolic risk factors.Aldosterone Predicts Cardiovascular, Renal, and Metabolic Disease in the General Community: A 4-Year Follow-Up Fructose Containing Sugars at Normal Levels of Consumption Do Not Effect Adversely Components of the Metabolic Syndrome and Risk Factors for Cardiovascular Disease.Aldosterone, C-reactive protein, and plasma B-type natriuretic peptide are associated with the development of metabolic syndrome and longitudinal changes in metabolic syndrome components: findings from the Jackson Heart Study The role of tissue Renin-Angiotensin-aldosterone system in the development of endothelial dysfunction and arterial stiffness.Relevance of a Hypersaline Sodium-Rich Naturally Sparkling Mineral Water to the Protection against Metabolic Syndrome Induction in Fructose-Fed Sprague-Dawley Rats: A Biochemical, Metabolic, and Redox Approach.Type 2 diabetes mellitus and hypertension: an update.From aldosteronism to oxidative stress: the role of excessive intracellular calcium accumulation.Mineralocorticoid receptor blockade in chronic kidney disease.Lipoproteins and Hedgehog signalling--possible implications for the adrenal gland function.The possibility of resistant hypertension during the treatment of hypertensive patients.Regulation of aldosterone synthesis and secretion.Mineralocorticoid receptor: a critical player in vascular remodeling.Crosstalk between adipose tissue and blood vessels in cardiometabolic syndrome: implication of steroid hormone receptors (MR/GR).Sanguinarine inhibits angiotensin II-induced apoptosis in H9c2 cardiac cells via restoring reactive oxygen species-mediated decreases in the mitochondrial membrane potential Effect of eplerenone in patients with heart failure and reduced ejection fraction: potential effect modification by abdominal obesity: Insight from the EMPHASIS-HF trial.Improvement in All-Cause Mortality With Blood Pressure Control in a Group of US Veterans With Drug-Resistant Hypertension.Risk of New-Onset Dyslipidemia After Laparoscopic Adrenalectomy in Patients with Primary Aldosteronism.Body Mass Index Predicts 24-Hour Urinary Aldosterone Levels in Patients With Resistant Hypertension.A novel bead-based fluorescence immunoassay for aldosterone.Increased urinary aldosterone excretion is associated with subcutaneous not visceral, adipose tissue area in obese individuals: a possible manifestation of dysfunctional subcutaneous adipose tissue.Study of aldosterone synthase inhibition as an add-on therapy in resistant hypertension.Aldosterone-to-renin ratio and home blood pressure in subjects with higher and lower sodium intake: the Ohasama study.Atorvastatin protects the proliferative ability of human umbilical vein endothelial cells inhibited by angiotensin II by changing mitochondrial energy metabolism.

P2860

Q26851506-3C161447-B216-41D1-A744-209BD4948898 Q26852612-242ABE19-7368-4387-9F75-5AA8017A08A5 Q26995642-5DE8AF45-5E90-4440-817F-A7D5D7726E36 Q30404992-C22DF316-6D35-4B3C-A926-ED763FE782D1 Q34062829-E8CAB292-9A87-4985-AC4D-C99CFFFC533F Q34409899-86F3BDDA-ACB3-45D5-A7A0-A16924A8DDCD Q34545558-F5B285ED-12E3-4041-95A6-39BACE169E8E Q34714245-1C2D6CB6-DC26-4964-B147-DC8445DB50B1 Q35071304-1790EE7D-FD63-4064-A10C-17FBE585F112 Q35113885-4A6B53C7-98F7-46FB-8335-B6D2C43431E0 Q35115799-AB8A1878-8494-42BC-B80D-A7E474CE7D0E Q35293123-08B4EA8B-0A0F-4AB8-A8C6-6F6901DEB7B2 Q35375027-74BE7786-DC1D-484E-8D82-4D2D41112E4C Q35906989-F4A362D9-E490-4D59-A32C-CB88B38EDC76 Q36072142-DBCE5E81-749B-44D8-93C1-9EDAC9AFC2AD Q36359078-C90C4CA9-ECD3-4370-B9A4-6628DE245BD8 Q36737227-A47D9913-732B-42CA-92CD-94E7C187FE81 Q36836343-35C7F297-1A04-4D62-9531-008F5B85A87C Q36846165-0124E524-AAFF-4E90-8E1D-071FA2B687EA Q37193640-9913C639-465E-4459-9751-00B2239B971D Q37261536-0A4D686E-3E66-43FC-BCDF-6BCBFB459E95 Q37615131-6C3E996F-8C5C-4E26-976C-F892E1356C04 Q37617567-5826FC78-7D15-409F-83BB-F56823141C63 Q37786549-66C3BC45-19AE-479B-AF7D-45A3681F3754 Q37861583-92326AEF-D1AF-4F6F-B0C5-067D3D323679 Q38132847-F69FC989-5862-442A-8964-C7B2C664E030 Q38136479-0FBF648C-9812-492B-987E-70C429B2E931 Q38221449-A8053272-0DBF-43F7-854F-70D5C96BD958 Q38238028-3C532880-3553-4026-9E68-B00D68E93173 Q38267493-2ED4EA51-E4AA-4C2D-9A51-201C096ACAB9 Q38870321-913296F1-B5F4-496C-89E0-5229A669073B Q39322673-CE569CD5-6200-4A41-9752-40CEA2D1EC88 Q40461830-89FB778A-994D-471C-BB1D-C0B0A59B06A0 Q40618492-F12719B1-BBA1-4214-BF34-C23CB978206D Q40620899-300DD66C-245A-4AF1-B56C-AD3BB0C39C88 Q41146855-521390BE-2B38-4A6E-B2FD-7BDC5CF49F25 Q43894263-CB290AAB-580A-4A14-BF4F-71861801C838 Q44119714-C28D11A0-B722-4542-B1F6-60F914FDB8E1 Q45129805-3775B734-3E42-4C51-9439-40D5F6931396 Q47098664-7CB0D427-F988-4C15-9E84-75101240A536

P2860

Aldosterone: role in the cardiometabolic syndrome and resistant hypertension

http://www.wikidata.org/entity/Q33736838

description

2010 nî lūn-bûn

@nan

2010 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մարտին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Aldosterone: role in the cardiometabolic syndrome and resistant hypertension

@ast

Aldosterone: role in the cardiometabolic syndrome and resistant hypertension

@en

type

label

Aldosterone: role in the cardiometabolic syndrome and resistant hypertension

@ast

Aldosterone: role in the cardiometabolic syndrome and resistant hypertension

@en

prefLabel

Aldosterone: role in the cardiometabolic syndrome and resistant hypertension

@ast

Aldosterone: role in the cardiometabolic syndrome and resistant hypertension

@en

P1433

Q33736838-AB315ECE-1E3A-400A-A57F-FEB4A3679BCC

P1476

Q33736838-DDFB092D-43C5-49E2-AFED-231538FD9F5B

P2093

Q33736838-021E0D21-9DA8-4BAB-9A92-47DFDE5249AB

Q33736838-9A9686A5-EA4E-4516-BE9F-9344EFEB5947

Q33736838-CFE702F6-5CE2-4EBF-ACE4-0B5BC4788A7C

P2860

Q33736838-033CE7AF-B0C5-4D00-8081-C67F7C7F4764

Q33736838-0629A150-7303-46C5-8C5F-A22F06BE5CF4

Q33736838-06C6C679-AA3C-49A7-83BD-A9FBAA51F8FD

Q33736838-0B0E5150-0331-4006-A632-D7E75146BFC0

Q33736838-0DAD31E9-8801-419F-AC02-3610C8D3FD79

Q33736838-11B35E7C-F0C9-4A43-8C31-F7FB1A1C0E0E

Q33736838-1230FC03-47BC-42C3-8935-3644BECA3A70

Q33736838-13E7D0AA-A9AE-4E3E-9BC0-602201EDB9D3

Q33736838-14F203E9-45F7-4E01-AB4C-E1E1D1622CAF

Q33736838-17753E08-F0EC-4C0F-9F13-A2F1E9A43DE7

P304

Q33736838-F2B58F13-7337-4CF3-8FBB-BE24FFB6DF7F

P31

Q33736838-658754C8-5D4B-4937-BE3D-B5244BD5CF9F

P356

Q33736838-39F0CC15-5C7D-4CE6-A959-647E3DE428B6

P433

Q33736838-65B2E534-6663-4F7F-BB25-00BAE69A013D

P478

Q33736838-FEC0460C-8718-4292-AA34-F117C7661D5F

P577

Q33736838-88CB6B33-9619-4CD9-9650-D8C97A721FFA

P5875

Q33736838-90D17E01-0763-4669-831E-C03A19DF01BB

P698

Q33736838-A458CF6F-0943-4AA9-94BC-EC48B7D95C52

P932

Q33736838-6857B0FC-F36D-41DD-A569-76E5109BFAB2

P356

J.PCAD.2009.12.004

P1433

Progress in Cardiovascular Diseases

P1476

Aldosterone: role in the cardiometabolic syndrome and resistant hypertension

@en

P2093

Adam Whaley-Connell

http://www.w3.org/2001/XMLSchema#string

James R Sowers

http://www.w3.org/2001/XMLSchema#string

Megan S Johnson

http://www.w3.org/2001/XMLSchema#string

P2860

Prevalence of overweight and obesity in the United States, 1999-2004

Cardiovascular and renal sympathetic activation by blood-borne TNF-alpha in rat: the role of central prostaglandins

Aldosterone induces angiotensin-converting-enzyme gene expression in cultured neonatal rat cardiocytes.

The obesity, metabolic syndrome, and type 2 diabetes mellitus pandemic: Part I. Increased cardiovascular disease risk and the importance of atherogenic dyslipidemia in persons with the metabolic syndrome and type 2 diabetes mellitus

Epithelial sodium channel regulated by aldosterone-induced protein sgk.

Narrative review: the emerging clinical implications of the role of aldosterone in the metabolic syndrome and resistant hypertension.

Interaction of aldosterone and extracellular volume in the pathogenesis of obesity-associated kidney disease: a narrative review

Mechanisms linking obesity with cardiovascular disease.

Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research.

The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994.

P304

401-409

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.PCAD.2009.12.004

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

52

http://www.w3.org/2001/XMLSchema#string

P577

2010-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41942479

http://www.w3.org/2001/XMLSchema#string

P698

20226958

http://www.w3.org/2001/XMLSchema#string

P932

2841057

http://www.w3.org/2001/XMLSchema#string